APT Medical

APT Medical ROA

The Return on Assets (ROA) of APT Medical (688617.SS) as of Oct 21, 2026 is 22.45 %. In the previous year, Return on Assets (ROA) was 22.58 % — a change of -0.59% (lower).

ROA

22.45 %

YoY

-0.59%

Last updated:

In 2025, APT Medical's return on assets (ROA) was 22.45 %, a -0.59% increase from the 22.58 % ROA in the previous year.

The APT Medical ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
6.60 CNY
Jan 1, 2019
14.72 CNY
Jan 1, 2020
18.82 CNY
Jan 1, 2021
10.33 CNY
Jan 1, 2022
16.08 CNY
Jan 1, 2023
20.75 CNY
Jan 1, 2024
22.58 CNY
Jan 1, 2025
22.45 CNY
The APT Medical ROA history
YEARROAYoY
22.45 %-0.59%
22.58 %+8.83%
20.75 %+29.02%
16.08 %+55.72%
10.33 %-45.11%
18.82 %+27.84%
14.72 %+122.93%
6.60 %-51.61%
13.64 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

APT Medical Stock analysis

What does APT Medical do? APT Medical Inc generates revenue through the research, development, production, and sale of electrophysiology, coronary access, and peripheral vascular intervention medical devices. The company offers electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters, and multichannel electrophysiological systems under its electrophysiology product line. Its coronary access segment includes guide wires, micro catheters, balloons, contrast guide wires, and catheters. Peripheral vascular intervention products address peripheral vascular diseases and are sold domestically and internationally. The firm also engages in original equipment manufacturer (OEM) business, producing products for other brands. Domestic and overseas markets are the primary sales channels for all product segments. The company's electrophysiology products target healthcare providers specializing in cardiac procedures, while coronary access devices serve interventional cardiologists and vascular surgeons. Peripheral vascular intervention solutions are marketed to hospitals and clinics treating vascular conditions. OEM partnerships allow APT Medical to supply components to other medical device manufacturers without direct branding. These segments collectively drive revenue through direct sales to healthcare institutions and international distributors. APT Medical Inc's product portfolio includes electrophysiological systems and coronary access tools that cater to specific medical specialties. The firm's peripheral vascular intervention products are designed for treating conditions like peripheral artery disease. OEM business contributes to revenue by manufacturing components for other companies' branded products. Domestic market sales and overseas distribution networks form the core of the company's commercial strategy, with no mention of specific customer names or financial figures beyond the employee count. APT Medical is one of the most popular companies on Eulerpool.

ROA Details

Understanding APT Medical's Return on Assets (ROA)

APT Medical's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing APT Medical's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider APT Medical's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in APT Medical’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about APT Medical stock

Return on Assets (ROA) of APT Medical is 22.45 % in 2025.

Return on Assets (ROA) of APT Medical changed from 22.58 % to 22.45 %, representing a -0.59% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) APT Medical since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s APT Medical with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — APT Medical

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — APT Medical